CombiMatrix Corporation
6500 Harbour Heights Parkway
Suite 303
Mukilteo,
WA 98275
United States - Map
Phone: 425-493-2000
Fax: 425-493-2010
Web Site: http://www.combimatrix.com
| CombiMatrix Corporation, together with its subsidiaries, develops technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology, defense, and homeland security. Its technologies include a platform to produce user-defined, in-situ synthesized, and oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations, and proteins in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology. The companys products and services include CustomArray platform, an oligonucleotide array for genetic studies; CatalogArray Microarrays for gene expression studies, mutation analysis, and other studies; Micro-RNA Arrays that are used to study micro-RNA molecules; DNA Array Synthesizer, an instrument that enables researchers to fabricate DNA arrays to their specifications; stripping reagents, which enable researchers to re-use microarrays; ElectraSense Reader, an electrochemical scanning instrument; and comparative genomic hybridization arrays, which are used for research and molecular diagnostic applications. CombiMatrix Corporation also offers proprietary molecular synthesis and screening methods for the discovery of potential new drugs. In addition, the company develops capabilities of producing arrays that utilize bacterial artificial chromosomes that enable genetic analysis; and a series of compounds to address various oncology-related diseases. It sells its products and services directly, with partners, and through distributors to customers in the United States, Europe, and Asia. The company was founded in 1995 and is based in Mukilteo, Washington. CombiMatrix Corporation operates independently of Acacia Research Corp. as of August 16, 2007. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Amit Kumar Ph.D., 44
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Scott R. Burell CPA, 44
Chief Financial Officer, Principal Accounting Officer, Sec. and Treasurer |
N/A
| N/A | Dr. Brooke P. Anderson Ph.D., 45
Chief Operating Officer, Director and Member of the Scientific Advisory Board |
N/A
| N/A | Dr. Mansoor Mohammed Ph.D., 37
Chief Exec. Officer of CombiMatrix Molecular Diagnostics Inc |
N/A
| N/A | Dr. Don Montgomery Ph.D.,
Chief Technology Officer, Sr. VP and Member of Scientific Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
